Abbott Laboratories vs. Quoin Pharmaceuticals, Ltd. American Depositary Shares
ABT
Abbott Laboratories
$108.61 -0.17%
VS QNRXQuoin Pharmaceuticals, Ltd. American Depositary Shares
$7.26 -7.75%
Abbott Laboratories (ABT) comes out ahead, leading on 5 of 5 compared factors.
Size & Scale
| ABT | QNRX | |
|---|---|---|
| Market Cap | $188.25 billion | $15.81 million |
| Revenue (TTM) | $46.59 billion | — |
| Net Income (TTM) | $5.42 billion | $-18,665,315 |
ABT leads on 2 of 2 size & scale factors.
Valuation
| ABT | QNRX | |
|---|---|---|
| P/E Ratio | 35.15 | — |
| Price / Book | 3.64 | 4.02 |
| Price / Sales | 4.04 | — |
ABT leads on 1 of 1 valuation factors.
Profitability
| ABT | QNRX | |
|---|---|---|
| Net Margin | 11.65% | — |
| Return on Equity | 10.48% | -474.62% |
ABT leads on 1 of 1 profitability factors.
Dividend
| ABT | QNRX | |
|---|---|---|
| Dividend Yield | 2.32% | — |
| Payout Ratio | 81.55 | — |
ABT and QNRX split the dividend factors evenly.
Risk & Sentiment
| ABT | QNRX | |
|---|---|---|
| Short Interest | 0.57% | 4.83% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, QNRX overview, QNRX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.